US State Peptide Laws & Regulations
Peptide regulations in the United States are primarily governed by federal law (FDA), but individual states may have additional requirements through their Boards of Pharmacy, health departments, or specific legislation.
Note: Most peptide regulation occurs at the federal level through the FDA. State variations primarily affect pharmacy compounding, dispensing requirements, and enforcement priorities. Always verify current regulations with state authorities.
State-by-State Overview
| State | Status | Summary |
|---|---|---|
| Alabama | Restricted | Peptides are restricted in Alabama through professional-licensure enforcement rather than a criminal statute naming peptides directly. Alabama has no statute... |
| Alaska | Gray Area | Peptides are in a legal gray area in Alaska because the state has no peptide-specific or 'research chemical' statute, administrative code, or Board of Pharmacy... |
| Arizona | Gray Area | Arizona has no statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category, so... |
| Arkansas | Gray Area | Arkansas has no statute or Board of Pharmacy rule that names peptides or 'research chemicals' as a distinct legal category; instead, peptide legality in... |
| California | Restricted | Peptides are restricted, not categorically banned, in California: the state has no statute that singles out "peptides" or "research chemicals" as their own... |
| Colorado | Gray Area | Peptides are not specifically named in any Colorado statute or Board of Pharmacy regulation as their own legal category; Colorado has no law that separately... |
| Connecticut | Gray Area | Connecticut has no statute, Board of Pharmacy regulation, or published bulletin that names "peptides," "research chemicals," or research-use-only compounds as... |
| Delaware | Gray Area | Peptides occupy a legal gray area in Delaware because the state has not enacted any statute or Board of Pharmacy regulation that names peptides or "research... |
| Florida | Gray Area | Florida peptide legality is a gray area because the state has no peptide-specific or research-chemical-specific statute, administrative rule, or Board of... |
| Georgia | Gray Area | Georgia has no peptide-specific or "research chemical"-specific statute: a search of the Georgia State Board of Pharmacy's administrative rules and recent... |
| Hawaii | Gray Area | Peptides in Hawaii are not legal or illegal as a single category; instead, Hawaii has no state statute, administrative rule, or Board of Pharmacy bulletin... |
| Idaho | Gray Area | Idaho has no statute, administrative rule, or Board of Pharmacy bulletin that singles out "peptides" or "research chemicals" as a distinct legal category, so... |
| Illinois | Gray Area | Peptides are not addressed by any Illinois-specific statute, administrative code section, or Board of Pharmacy rule naming peptides or "research chemicals" as... |
| Indiana | Gray Area | Peptides are in a legal gray area in Indiana: there is no Indiana statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or... |
| Iowa | Gray Area | Peptides are in a legal gray zone in Iowa because no Iowa statute, administrative rule, or Board of Pharmacy bulletin singles out peptides or 'research... |
| Kansas | Gray Area | Kansas has no peptide-specific statute or Board of Pharmacy regulation that separately names 'peptides' or 'research chemicals' as a distinct legal category,... |
| Kentucky | Gray Area | Kentucky has no peptide-specific or 'research chemical' statute for general human use; the Kentucky Board of Pharmacy instead applies its ordinary compounding... |
| Louisiana | Gray Area | Louisiana has no identified statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal... |
| Maine | Gray Area | Peptides are in a legal gray area in Maine because the state has never enacted a peptide-specific or "research chemical" statute, leaving peptide products to... |
| Maryland | Gray Area | Maryland has no statute, administrative code section, or Board of Pharmacy rule that singles out 'peptides' or 'research chemicals' as a distinct legal... |
| Massachusetts | Gray Area | Massachusetts has no peptide-specific law: the state legislature and the Massachusetts Board of Registration in Pharmacy have not enacted a statute or... |
| Michigan | Gray Area | Peptides are in a legal gray zone in Michigan: the state has no statute or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct... |
| Minnesota | Gray Area | Minnesota has no peptide-specific or "research chemical"-specific statute; instead, peptides are regulated indirectly through the state's general pharmacy... |
| Mississippi | Gray Area | Mississippi has no peptide-specific, research-chemical-specific, or BPC-157-specific statute or administrative rule; the Mississippi Board of Pharmacy... |
| Missouri | Gray Area | Peptides are not specifically addressed by Missouri law; the state defers to the general federal framework administered by the FDA and the... |
| Montana | Gray Area | Peptides are legally gray in Montana: the state has no statute or Board of Pharmacy rule that specifically names peptides, 'research chemicals,' or... |
| Nebraska | Gray Area | Nebraska has no statute, administrative regulation, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category.... |
| Nevada | Restricted | Peptides are restricted in Nevada through a combination of federal FDA compounding law and Nevada State Board of Pharmacy enforcement rather than through any... |
| New Hampshire | Gray Area | New Hampshire has no peptide-specific law, administrative rule, or Board of Pharmacy bulletin naming BPC-157, TB-500, GLP-1 peptides, or 'research chemicals'... |
| New Jersey | Gray Area | New Jersey has no peptide-specific or "research chemical"-specific statute; the New Jersey State Board of Pharmacy regulates compounding generally under... |
| New Mexico | Gray Area | New Mexico has no statute, administrative code section, or Board of Pharmacy rule that names peptides, 'research chemicals,' or research-use-only compounds as... |
| New York | Gray Area | New York has no statute, regulation, or Board of Pharmacy rule naming "peptides" or "research chemicals" as a distinct legal category, so peptide legality in... |
| North Carolina | Gray Area | North Carolina has no statute or Board of Pharmacy rule that uses the terms "peptide" or "research chemical" as a defined legal category, so peptide products... |
| North Dakota | Gray Area | North Dakota has no statute, administrative rule, or Board of Pharmacy bulletin that names peptides, "research chemicals," or research-use-only compounds as a... |
| Ohio | Gray Area | Ohio has no identified statute, administrative code section, or Board of Pharmacy rule that singles out "peptides" or "research chemicals" as their own... |
| Oklahoma | Gray Area | Oklahoma has no state statute, administrative code section, or Board of Pharmacy rule that specifically names 'peptides,' 'research chemicals,' or... |
| Oregon | Gray Area | Peptides are legal in Oregon only when they are FDA-approved prescription drugs (such as branded semaglutide/tirzepatide or prescription human growth hormone)... |
| Pennsylvania | Gray Area | Pennsylvania has no peptide-specific, research-chemical-specific, or research-use-only statute; the state simply relies on its general Pharmacy Act and Board... |
| Rhode Island | Gray Area | Peptides are in a legal gray zone in Rhode Island: no state statute or Board of Pharmacy regulation creates a distinct 'peptide' or 'research chemical'... |
| South Carolina | Gray Area | South Carolina has no state statute, administrative regulation, or Board of Pharmacy rule that names peptides or 'research chemicals' as a distinct legal... |
| South Dakota | Gray Area | South Dakota has no peptide-specific or "research chemical"-specific statute or Board of Pharmacy rule, so the legal status of any given peptide in South... |
| Tennessee | Gray Area | Peptides do not have a dedicated Tennessee statute; Tennessee has no law that names 'peptides' or 'research chemicals' as a distinct legal category. Instead,... |
| Texas | Gray Area | Peptides are legal in Texas only when they follow the same federal framework used in every state: FDA drug approval, or lawful compounding under Sections... |
| Utah | Gray Area | Utah has no statute, administrative rule, or Board of Pharmacy regulation that names peptides, "research chemicals," or research-use-only compounds as a... |
| Vermont | Gray Area | Peptides occupy a legal gray zone in Vermont because the state has no statute or Board of Pharmacy rule that names peptides, research chemicals, or... |
| Virginia | Gray Area | Virginia has no statute or Board of Pharmacy regulation that names "peptides," "research chemicals," or research-use-only compounds as a distinct legal... |
| Washington | Gray Area | Washington State has no statute or administrative code that names 'peptides' or 'research chemicals' as their own legal category; instead, peptide legality in... |
| West Virginia | Gray Area | West Virginia has no peptide-specific or 'research chemical' statute; state law simply layers the West Virginia Board of Pharmacy's compounding and licensing... |
| Wisconsin | Gray Area | Wisconsin has no law, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category.... |
| Wyoming | Gray Area | Peptides are not addressed by any Wyoming-specific statute, administrative code, or Board of Pharmacy rule; Wyoming has no law naming 'peptides' or 'research... |
Understanding State vs Federal Regulation
Federal Authority (FDA)
The FDA has primary authority over drug regulation, including peptides. Key federal regulations include:
- Drug approval requirements under the FD&C Act
- Compounding pharmacy oversight (503A and 503B)
- Import/export controls
- Labeling and marketing requirements
State Authority
States primarily regulate through:
- Boards of Pharmacy: Licensing, compounding standards, dispensing rules
- Health Departments: Public health oversight, clinic regulations
- Attorney General: Consumer protection enforcement
- Legislature: State-specific controlled substance schedules
Key Differences by State
State variations typically affect:
- Compounding pharmacy requirements and inspections
- Telemedicine and telehealth prescribing rules
- Enforcement priorities and resources
- State-scheduled controlled substances (beyond federal DEA schedules)